A5086064762- SARS-CoV-2 and COVID-19 Research
- Pneumonia and Respiratory Infections
- Vaccine Coverage and Hesitancy
- vaccines and immunoinformatics approaches
- COVID-19 Clinical Research Studies
LRS Institute of Tuberculosis and Respiratory Diseases
2021
Background India began COVID-19 vaccination in January 2021, initially targeting healthcare and frontline workers. The strategy was expanded a phased manner currently covers all individuals aged 18 years above. experienced severe second wave of during March–June 2021. We conducted fourth nationwide serosurvey to estimate prevalence SARS-CoV-2 antibodies the general population ≥6 workers (HCWs). Methods findings did cross-sectional study between 14 June 6 July 2021 same 70 districts across 20...
Background: India witnessed a severe second wave of COVID-19 during March and June 2021. We did the fourth nationwide serosurvey to estimate prevalence SARS-CoV-2 antibodies in general population aged >=6 years health care workers (HCWs). Methods: cross-sectional study between 14 6 July 2021 700 clusters same 70 districts across 21 states/Union Territory. From each district, minimum 400 individuals from 100 HCWs district public facilities were included. The serum samples tested for presence...